Cancer Science · 2019 · 35 citations · 29 references
MedicineOncologyPharmacologyMetastasisNeoplasiaTumor ProgressionCancer Cell SignalingCancer Molecular PathologyCancer ProgressionMalignant NeoplasmsPancreatic DiseasesCancer Metastasis MechanismsMetastasis ModelsMetastatic Pancreatic CancerPancreatic Cancer Liver MetastasisPancreatic MetastasesPeritoneal DisseminationTumor Metastasis Biology
Abstract Vasohibin‐2 ( VASH 2) is expressed in various cancers and promotes their progression. We recently reported that pancreatic cancer patients with higher VASH 2 expression show poorer prognosis. Herein, we sought to characterize the role of VASH 2 in pancreatic cancer. We used LSL ‐Kras G12D ; LSL ‐Trp53 R172H ; Pdx‐1‐Cre ( KPC ) mice, a mouse model of pancreatic ductal adenocarcinoma ( PDAC ), and cells isolated from them ( KPC cells). Knockdown of Vash2 from PDAC cells did not affect their proliferation, but decreased their migration. When Vash2‐knockdown PDAC cells were orthotopically inoculated, liver metastasis and peritoneal dissemination were reduced, and the survival period was significantly prolonged. When KPC mice were crossed with Vash2 ‐deficient mice, metastasis was significantly decreased in Vash2 ‐deficient KPC mice. VASH 2 was recently identified to have tubulin carboxypeptidase activity. VASH 2 knockdown decreased, whereas VASH 2 overexpression increased tubulin detyrosination of PDAC cells, and tubulin carboxypeptidase ( TCP ) inhibitor parthenolide inhibited VASH 2‐induced cell migration. We next clarified its role in the tumor microenvironment. Tumor angiogenesis was significantly abrogated in vivo when VASH 2 was knocked down or deleted. We further examined genes downregulated by Vash2 knockdown in KPC cells, and found chemokines and cytokines that were responsible for the recruitment of myeloid derived suppressor cells ( MDSC ). Indeed, MDSC were accumulated in PDAC of KPC mice, and they were significantly decreased in Vash2 ‐deficient KPC mice. These findings suggest that VASH 2 plays an essential role in the metastasis of PDAC with multiple effects on both cancer cells and the tumor microenvironment, including tubulin detyrosination, tumor angiogenesis and evasion of tumor immunity.
29